An effective pricing strategy is a key component of the international marketing plan. Many factors influence pricing decisions including corporate objectives, market size, price controls and reimbursement systems in the different markets, number of close comparators, prices of competitors, etc. A strategy built around a uniform global price for a product is usually not feasible because of different regulations and expectations in the various markets. When customers differ in terms of willingness to pay, a differential pricing strategy may yield maximum revenues, however the risk of competition from parallel imports is also a factor in some markets. Setting a premium price may limit market access as a product may not be reimbursed or may have limited reimbursement under public and/or private health plans.

Governments are concerned with rising health care costs, and many are taking steps to restrict the prices of pharmaceuticals especially if they will be reimbursed by health plans. Government interventions in the pharmaceutical market include:

• Price and profit controls

• Formularies and negative lists

• Price negotiations and risk management agreements

• International price comparisons

• Reference pricing

• Health economic requirements

Pricing should be managed throughout the product's life cycle to ensure that the pricing strategy is responsive to changes in the market place and continues to produce optimal sales. PDCI Market Access can work with you to build an effective pricing strategy for your product. We can provide expertise in the following areas:

• Defining pricing objectives

• International market analysis - European Union, United States, Japan, Canada and emerging markets

• Identifying government regulations and policies impacting on pricing and reimbursement in each market and developing strategies to manage them

• Competitor pricing analysis

• Product life cycle pricing

• Designing innovative pricing strategies for biopharmaceuticals

• Evaluating the risks of parallel trade

For more information please contact Neil Palmer, Janice D'Angelo or Susan Neale

International Pharmaceutical Pricing Data

PDCI Market Access has developed a comprehensive database of international pharmaceutical prices.   The data are invaluable for conducting primary pricing research for drugs in development (e.g., go, no-go decisions), for global pricing & reimbursement strategies for new drugs or filing with regulatory authorities (e.g. PMPRB in Canada).   

Prices for the following countries are available:

The price database has been assembled from the official published price lists in each country.  Wholesale and pharmacy prices are recorded for all dosage forms, strengths and package sizes. Ex-factory prices have been calculated by adjusting the published prices to remove mark-ups, VAT, etc.  The adjustments are based on the official algorithms / formulae published in each country.

The data can be provided in local currencies and/or standardized to a single currency (e.g., Euros, US Dollars, British Pounds, Canadian Dollars).

Data are provided to clients on a request basis and can be customized to reflect the specific drugs needed and can be delivered in a variety of formats from printed reports to excel spreadsheets.  A sample report is available for downloading.  Larger requests can be provided in a database format complete with report writer and exchange calculator.

The cost is dependent on number of data elements requested.  We typically complete small requests within 24 hours and larger requests within 5 business days.

For further information on PDCI Market Access’s International Price Database please contact Arvind Mani.

Global Network of Pricing & Reimbursement Experts

In collaboration with expert consultants in major markets in Europe and North America, PDCI Market Access undertakes global P & R projects for clients around the world.

An effective P & R strategy is a key component of the international marketing plan. Many factors influence decisions including corporate objectives , market size, price controls and reimbursement systems in the different markets, number of close comparators, prices of competitors, etc. A strategy built around a uniform global price for a product is often not feasible because of different regulations and expectations in the various markets. When customers differ in terms of willingness to pay, a differential pricing strategy may yield maximum revenues, however the risk of competition from parallel imports is also a factor in some markets. Setting a premium price may limit market access as a product may not be reimbursed or may have limited reimbursement under public and/or private health plans.

PDCI Market Access can work with you to build an effective P & R strategy for your product. Our international collaborators have local experience, expertise and contacts to ensure that we provide the best possible strategic advice and dossiers. In addition to our International Price Database we can provide expertise in the following areas:

• Defining P & R objectives

• International P & R analysis – United States, Canada and other major markets

• Identifying government regulations and policies impacting on P & R in each market and developing strategies to manage them

• Competitor pricing analysis

• Product life cycle pricing

• Designing innovative P & R strategies for biopharmaceuticals

• Evaluating the risks of parallel trade

For more information please contact Neil Palmer, Janice D’Angelo or Susan Neale